Eric Ostertag, Chief Executive Officer at Poseida Therapeutics, Inc. (PSTX), sold 37,848 shares at $7.09 ($268K) on 2021-11-08, disclosed to the SEC on 2021-11-10.
Open-market sale of $268k PSTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.09 | 9,051 | $64K | 23.9% |
| 2 | $7.09 | 9,051 | $64K | 23.9% |
| 3 | $7.09 | 9,873 | $70K | 26.1% |
| 4 | $7.09 | 9,873 | $70K | 26.1% |
| Total | $7.09 avg | 37,848 | $268K | 100% |
| Filing → |
| PSTX | SELL | 2021-10-05 | $208K | — | Filing → |
| PSTX | SELL | 2021-09-22 | $160K | — | Filing → |
| PSTX | SELL | 2021-09-15 | $163K | — | Filing → |